Health
Bedside trial of COVID-19 ICU patients sees hydrocortisone improve recovery – Mirage News
Researchers have found that intravenous hydrocortisone improves recovery and survival for critically ill COVID-19 patients. The finding comes as a result…
- Researchers have found that intravenous hydrocortisone improves recovery and survival for critically ill COVID-19 patients.
- The finding comes as a result of the REMAP-CAP trial that was set up by a group of intensive care specialists from around the world to future-proof for pandemics like COVID-19.
- COVID-19 patients from more than 200 intensive care units around the world have been part of this adaptive randomised trial.
A global study, led from Mo…
Click here to view the original article.
Continue Reading
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News21 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving
-
Noosa News23 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News15 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track